(Q38346075)

2 September 2017

1 reference

title

N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? (English)

1 reference

2 September 2017

Albers GW

1

1 reference

PubMed ID

2565699

2 September 2017

Goldberg MP

series ordinal

2

1 reference

PubMed ID

2565699

2 September 2017

Choi DW

series ordinal

3

1 reference

2 September 2017

1 April 1989

1 reference

2 September 2017

1 reference

2 September 2017

25

1 reference

2 September 2017

398-403

1 reference

2 September 2017

4

1 reference

Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters

2 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FANA.410250412

Mechanisms involved in irreversible anoxic damage to thein vitrorat hippocampal slice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410250412

Delayed hippocampal damage in humans following cardiorespiratory arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410250412

Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410250412

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410250412

Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410250412

21 January 2018

Identifiers

DOI

10.1002/ANA.410250412

1 reference

2 September 2017

1 reference

PubMed ID

2565699